Swedish Orphan Biovitrum Logo

Swedish Orphan Biovitrum

SOBI | ST

Overview

Corporate Details

ISIN(s):
SE0000872095 (+51 more)
LEI:
549300124Y3MQI87PT35
Country:
Sweden
Address:
Tomtebodavagen 23A, 112 76 Stockholm
Sector:
Health Care
Industry:
Biotechnology

Description

At Sobi, we are transforming life for people with rare diseases. As an international biopharmaceutical company, we provide access to innovative treatments in the areas of haematology, immunology and specialty care. - Two therapeutic areas – Haematology and Immunology – and a portfolio of products within Specialty Care - Our extended half-life factor replacement treatments are the most prescribed treatments for haemophilia - A and B respectively in several markets - A strong portfolio of on-market products, and an extensive portfolio of pre-market assets - An international biopharmaceutical company covering the entire value chain - We put our focus where we can have the greatest impact, in late-stage research and development, and in patient access and commercialisation

Social Media

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-05-08 11:30
Declaration of Voting Results & Voting Rights Announcements
Kommuniké från Sobis årsstämma
Swedish 148.7 KB
2025-05-08 11:30
Declaration of Voting Results & Voting Rights Announcements
Bulletin from Sobi’s Annual General Meeting (AGM)
English 158.7 KB
2025-04-29 08:00
Earnings Release
Swedish 4.1 MB
2025-04-29 08:00
Earnings Release
English 4.1 MB
2025-02-05 08:01
Earnings Release
Swedish 4.1 MB
2025-02-05 08:01
Earnings Release
English 4.0 MB
2025-01-10 18:00
Earnings Release
Sobis intäkter för helåret 2024 högre än tidigare uppskattningar
Swedish 144.9 KB
2025-01-10 18:00
Earnings Release
Sobi's full year 2024 revenue higher than previous estimate
English 156.9 KB
2024-12-11 09:30
Declaration of Voting Results & Voting Rights Announcements
Kommuniké från Sobis extra bolagsstämma
Swedish 131.8 KB
2024-12-11 09:30
Declaration of Voting Results & Voting Rights Announcements
Bulletin from Sobi’s Extraordinary General Meeting (EGM)
English 129.2 KB
2024-10-24 08:01
Earnings Release
Swedish 4.1 MB
2024-10-24 08:01
Earnings Release
English 4.1 MB
2024-08-29 14:45
Declaration of Voting Results & Voting Rights Announcements
Sobi har genomfört emissioner av C-aktier
Swedish 150.2 KB
2024-08-29 14:45
Transaction in Own Shares
Sobi has completed issues of class C shares
English 149.4 KB
2024-08-08 13:00
Earnings Release
Sobi and Apellis announce positive topline results from phase 3 VALIANT study o…
English 219.4 KB

Insider Transactions

Date Insider Name Position Type Shares Value
2024-08-30 Katy Mazibuko Other Sell 1,500 480,000.00 SEK
2024-08-30 Katy Mazibuko Other Sell 269 86,012.75 SEK
2024-08-12 Sara Karlsson Other Buy 86 23,391.79 SEK
2024-07-25 Mahmood Ladha Other Buy 84,585 12,360,406.05 SEK
2024-07-23 Mahmood Ladha Other Sell 84,585 24,614,235.00 SEK
2024-06-10 Christin Wesström Other Other 7,433 N/A
2024-06-03 Guido Oelkers Other Buy 117,332 23,965,061.00 SEK
2024-05-30 Guido Oelkers Other Sell 117,332 32,090,302.00 SEK
2024-05-15 Henrik Stenqvist Other Buy 72,534 14,815,069.50 SEK
2024-05-13 Henrik Stenqvist Other Sell 72,534 20,766,484.20 SEK

Peer Companies

Company Country Ticker View
1NKEMIA Logo 1NKEMIA Spain IKM
2cureX AB Logo 2cureX AB Sweden 2CUREX
4SC AG Logo 4SC AG Germany VSC
Abera Bioscience AB Logo Abera Bioscience AB Sweden ABERA
ABIONYX Pharma Logo ABIONYX Pharma France ABNX
Abliva Logo Abliva Sweden ABLI
AB Science Logo AB Science France AB
Acticor Biotech Logo Acticor Biotech France ALACT
Active Biotech Logo Active Biotech Sweden ACTI
AcuCort AB Logo AcuCort AB Sweden ACUC